Portfolio company
Inimmune
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops immunotherapies and vaccine components to treat patients with allergies, cancer, infectious diseases and autoimmune conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
immunique
This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Thymmune
This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.
Immunic Therapeutics
The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Georgiamune
This biotechnology company develops immunotherapies that reprogram immune signalling pathways to treat patients with cancer and autoimmune diseases.
Imagene
This clinical-stage biotechnology company develops therapeutics for patients with immunological, autoimmune and inflammatory diseases to improve quality of life.
